ArticleBlood advances2023

T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy.

Claire Horgan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.